In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps)
CA 2394052 C · Owner: Medimmune, Inc. · Inventors: Mccarthy, Michael P.; Suzich, Joanne A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of disassembly/reassembly of papillomavirus VLPs is provided. The resultant VLPs have enhanced homogeneity present conformational, neutralizing , PV epitopes and therefore are useful prophylactic and diagnostic agents. Further, these VLPs can be used to encapsulate desired moieties e.g. therapeutic or diagnostic agents, or "marker" DNAs and the resultant VLPs , used as in vivo delivery vehicles or as pseudovirions for evaluating vaccine efficacy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 8, 2000 and granted March 17, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 8, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 8, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.